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Abstract
Overcoming continuing polarization regarding judicial enforcement of health rights in Latin America requires clarifying
divergent normative and political premises, addressing the lack of reliable empirical data, and establishing the
conditions for fruitful inter-sectoral, inter-disciplinary dialogue.
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Background
Although an extremely diverse region, Latin America
poses a series of challenges for achieving equity in
health. First, both overall and within many individual
countries high degrees of socio-economic inequality are
refracted along racial, gender and ethnic lines, according
to distinct demographic configurations. Health is an
acute reflection of overall patterns of inequality and dis-
crimination and, as elsewhere, social determinants con-
tribute more to patterns and burdens of disease than
medical care in the region [1]. The region is also deeply
influenced by political determinants of health, defined
by the Lancet-Oslo Commission in 2014 as the “norms,
policies, and practices that arise from transnational
interaction” [2]. For example, Argentina faces Inter-
national Monetary Fund prescriptions, including auster-
ity policies, which affect population health through
multiple pathways.
Second, Latin America suffers from a generalized ten-
dency toward both political and regulatory dysfunction.
The former impairs the ability to collectively arrive at
democratically justified decisions regarding health in
particular, and social policy more broadly. The latter
means that issues often addressed through administra-
tive rule-making in other contexts present gaps or “gray
zones,” and regulatory oversight is weak. Both political
capture and polarization, and the lack of robust and ef-
fective regulation of public and private actors have par-
ticularly dramatic—and often gendered—impacts on
health across the region.
Third, Latin America is characterized by fragmented, and
highly medicalized health systems, which affects everything
from financing to priority-setting to organization and
delivery of care. As the burden of disease due to non-
communicable diseases has grown as a proportion of the
total disease burden, the medicalization of health systems
has accelerated. Fragmentation as well as inequities can also
be exacerbated in federalist systems where health provision,
as well as social policy that affects health, is decentralized
[3], such as Argentina.
Finally, many countries in the region have recognized
the right to health autonomously in their constitution or
by incorporation through international treaties, or both,
and others have interpreted the right to life in ways that
include aspects of health and health care. In turn, in
these countries, individual protection writ actions
(amparos, tutelas) can be used to obtain health–related
entitlements from courts with relative ease. Some
scholars and policy-makers to argue that judicial en-
forcement of health rights undermines equity as well as
systematic efforts to achieve Universal Health Coverage
(UHC) in accordance with the Sustainable Development
Goals. In a 2017 comment in the Lancet, a multi-
disciplinary group of authors debunked the blanket as-
sumption of a conflict between judicialization and
priority-setting [4]. Nevertheless, in Latin America,
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where individual protection writ actions for entitlements
have run into the hundreds of thousands in some
countries, these debates persist. In our view, over-
coming continuing polarization requires clarifying di-
vergent normative and political premises, addressing
the lack of reliable empirical data, and establishing
the conditions for fruitful inter-sectoral, inter-disciplinary
dialogue.
Points of departure: health systems, priority-setting, and
the role of courts
Our starting point is, first, that if health is understood as
a right, health systems must be understood as demo-
cratic social institutions that cannot be divorced from
the quality and texture of the democracies in which they
exist. A health system organized around the right to
health is analogous to a justice system organized around
the right to a fair trial, or an electoral system organized
around the right of political participation [5].
Second, all rights require resources and have distribu-
tional consequences. Some impacts are more visible than
others, due to historic trajectories and financing
employed in the institutional arrangements that support
the right (e.g. taxes versus employment-based or social
insurance). All rights also have collective and individual
dimensions. For example, the right of due process re-
quires a fair justice system (financed generally through
taxes) but also calls for rules to be applied fairly in spe-
cific cases. Similarly, the right to health requires a fairly
financed and just set of institutions and priority-setting
processes by which the contours of an enforceable en-
titlement are defined. At the same time, individuals have
both freedoms and entitlements within the system.
We need not reflexively accept that a health budget is
fair at any given moment to note that no country in the
world meets all health needs. Thus, the pressing ques-
tion, as Norman Daniels has written, is how can we
meet them fairly? [6] There is now a broad consensus
that, a fair and legitimate process should be, at a mini-
mum: (1) transparent and accessible to the public; (2)
based on reasons relevant to advancing population
health (i.e. not on religious arguments); (3) revisable in
light of new evidence and arguments that may apply to a
specific case, and (4) subject to regulation and enforce-
ment [6]. Further, increasingly, health scholars and
ethicists, argue that meaningful citizen participation is
necessary for democratic legitimacy [7]. Moreover,
priority-setting must be institutionalized as multiple
conditions change over time, and new evidence and in-
terventions become available.
By contrast, implicit priority-setting, which is widely
practiced in the region, relies on waiting lines, prices,
shortages, bureaucratic delays, etc., to ration access to
care [8]. Implicit priority-setting, which is inherently
untransparent, may be more politically palatable in the
short term. However, it is neither just (the well-off have
better access; it fosters substantial inequities); nor does
it enhance the legitimacy of the health system as a
democratic institution in the long term. A WHO Task
Force on Fair Choices on the Path to UHC noted the
ethical imperative of explicit priority-setting [9]. A
Policy Forum on Health Technology Assessments in
the region, held in 2018, came to the same conclu-
sion [10].
Finally, just as with other fundamental social institu-
tions in a democracy, as guardians of our constitutional
values, courts have an inherent role to play in ensuring
that the health system reflects those shared norms of
dignity and equality, whether addressing individual enti-
tlements or collective actions [11]. High courts in Latin
America have been able to establish principles and cri-
teria relating to the functioning of a democratic health
system, including: obligations of comprehensive and
continuous care; regulation of private providers and in-
surers; periodic processes relating to determination of
benefits; and rights to information (related to care as
well as social determinants of health). In some instances,
judgments have catalyzed important political action, by
both the executive and legislature, such as a new
statutory law on health in Colombia, or further regu-
lation of pharmaceuticals, sugary beverages, alcohol
and tobacco [5].
What we know about the categories of individual litigation
and judicial enforcement of health rights
Judicialization is complex and arises in various configura-
tions across different countries; broad-brush-assessments
are likely to be misleading or inaccurate. Nonetheless, al-
though there are cases that combine aspects of each cat-
egory and there are overlaps, it is useful to distinguish
between three general types of litigation for individual en-
titlements. First, a significant portion of health rights liti-
gation in the region relates to the enforcement of health
entitlements to which health system users should already
have access to but do not due to administrative failures
and other obstacles in practice. This type of litigation
often responds to regulatory compliance gaps. It is neither
inconsistent with systematic priority-setting, nor should it
be characterized as judicial activism. However, it may ex-
acerbate inequities if the compliance gaps are not closed.
A second pattern of health rights litigation involves
entitlements that fall into gray areas. Patients may liti-
gate due to a lack of clarity regarding what is included
in a health package (e.g. a prosthetic as well as the actual
surgery for joint replacement, etc.). Others may litigate
because they are denied a good or service without justifi-
cation. The first set of cases point to a regulatory failure
in the system; the latter set of cases may also point to
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regulatory failure, or to lack of transparency in the
priority-setting process. In both instances, purposive ju-
dicial enforcement should incentivize more clarity and
improved priority-setting processes. However, just as in
compliance gap cases, in practice judicial enforcement of
such entitlements can function more as an “escape
valve” perpetuating the regulatory dysfunction in the
system.
A third set of cases involves entitlements—especially,
but not exclusively, costly medicines—that are expressly
excluded from health schemes. Insofar as the exclusion
is based upon both the application of legitimate criteria
(e.g., lack of clinical effectiveness; lack of cost-effectiveness;
weak evidence) within a legitimate priority-setting process,
the ad hoc granting of health entitlements by courts
to those who have access is not conducive to advan-
cing equity across geographic regions or fragmented
health systems [12].
We need to know more about the dynamics of priority
setting and judicialization to evaluate impacts and
respond effectively
To understand the impacts on equity, as well as greater
oversight or other social values we care about, we need
to understand not just what is being litigated but who is
litigating and what the direct and indirect impacts are.
That is: (1) who are the claimants (class, gender, race,
and other indicators of social status; geographic regions)
?; (2) what are the success rates for different kinds of
claims?; and (3) what are the direct and indirect impacts
of cases [13], including how the costs are borne? For ex-
ample, repeated litigation may lead to revising criteria
for mandatory insurance schemes. However, clusters of
cases may become “routinized” [14] and produce sys-
temic transaction costs, as has occurred in Argentina.
Further, universalization may be ethically justified, drive
the price of medication or a service down, and promote
equity; however, it may also respond to disproportionate
political clout of a given patient community, or pharma-
ceutical industry advocacy.
In short, extrapolating conclusions at any given time or
across different countries is likely to be fallacious without
more granular information. Just as transparent data is ne-
cessary in a justice system, an electoral system or an edu-
cation system to determine efficiency and fairness, so too
do we need urgently better and more accessible informa-
tion to enable a more accurate assessment of the dynamics
between priority-setting processes, regulatory oversight
and judicialization [15]. Ideally, such information would
be presented in transparent and accessible format as close
to real-time as possible, which permits comparative ana-
lyses across time and both sub-national and national
contexts.
Conclusions
Advancing health —and social—equity in the region re-
quires addressing the broader factors that promote sys-
tematic exclusion and disadvantage. Nonetheless, we
have argued here that health systems should be under-
stood as social determinants themselves, which can
function as spaces to mitigate exclusion and weave to-
gether fragmented and deeply polarized societies. A fun-
damental role for such a social institution is a
democratically legitimate as well as scientifically valid
process for defining the contours of claimable entitle-
ments, which is then subsequently regulated. Thus,
democratically legitimate priority-setting should be seen
as part of designing a health system based upon the right
to health, not in conflict with it. Such processes should
be explicit, recognizing that implicit priority-setting does
not provide transparency or morally acceptable justifica-
tion, and incorporate meaningful citizen participation.
This analysis points to the need for dialogue between
judicial and legal actors, and health policymakers in the
region relating to the importance of and their potential
roles in enhancing fair and legitimate priority-setting
processes. Further, it underscores the importance of im-
proved and more actionable information to better
understand, and in turn effectively address, the dynamics
between priority-setting, regulation and judicial enforce-
ment of entitlements within and across contexts.
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